Results 121 to 130 of about 2,772,070 (240)

Race, wealth and health: The role of reparations. [PDF]

Soc Sci Med
Whittaker S, Hyacinthe MF, Keene D, Dulin A, Kershaw T, Warren J.   +5 more
europepmc   +1 more source

The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme. [PDF]

Antimicrob Agents Chemother, 2016
Warrilow AG, Parker JE, Price CL, Nes WD, Garvey EP, Hoekstra WJ, Schotzinger RJ, Kelly DE, Kelly SL.   +8 more
europepmc   +1 more source

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.

JAMA Netw Open
Andrews LIB, Halloran ME, Neuzil KM, van der Laan L, Huang Y, Andriesen J, Patel M, Fisher LH, Janes H, Rouphael N, Walsh SR, Theodore DA, Tieu HV, Sobieszczyk M, El Sahly HM, Baden LR, Falsey AR, Campbell TB, Kelley CF, Healy CM, Immergluck L, Luft B, Hirsch I, de Bruyn G, Truyers C, Priddy F, Sumner KM, Flannery B, Follmann D, Gilbert PB, COVID-19 Prevention Network (CoVPN).   +30 more
europepmc   +1 more source

United States of America vs. Marcus Garvey ::was justice defeated?

, 2010
Garvey, Marcus,
core  

Garvey Tells His Own Story

, 2000
MARCUS GARVEY
core   +1 more source

HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function. [PDF]

J Neurovirol
McLaurin KA, Li H, Khalili K, Mactutus CF, Booze RM.   +4 more
europepmc   +1 more source

More Philosophy and Opinions of Marcus Garvey

, 2012
Amy Jacques Garvey
core   +1 more source

Multi-level factors influencing HIV risk behaviors and oral PrEP use among Black and Latino men with heterosexual contact in New York City. [PDF]

PLoS One
Gatanaga OS, Lanza DV, Pitts RA, Braithwaite RS, Lim S.   +4 more
europepmc   +1 more source

Chronology: The life of Marcus Garvey [PDF]

, 1987
openaire   +1 more source

SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.

JAMA Netw Open
Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H, COVID-19 Prevention Network (CoVPN).   +30 more
europepmc   +1 more source